Clinical Practice Guidelines in Cardio-Oncology: A Sea of Opportunity

Overview

Journal JACC CardioOncol

Specialty Cardiology & Vascular Diseases

Date 2023 Mar 6

PMID 36875908

Authors

Kazuhiro Sase

Mikio Mukai

Yasuhiro Fujiwara

Affiliations

Soon will be listed here.

Citing Articles

Association Between Amount of Physical Activity and Clinical Outcomes After Treatment for Cardiovascular Disease in Cancer Survivors.

Nozaki K, Hamazaki N, Kamiya K, Ueno K, Miki T, Nanri Y Circ Rep. 2024; 6(12):547-554.

PMID: 39659630 PMC: 11625881. DOI: 10.1253/circrep.CR-24-0105.

Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics.

Abboud K, Umoru G, Trachtenberg B, Ajewole V Cardiooncology. 2024; 10(1):22.

PMID: 38594785 PMC: 11003064. DOI: 10.1186/s40959-024-00221-5.

References

Alexandre J, Cautela J, Ederhy S, Damaj G, Salem J, Barlesi F . Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines. J Am Heart Assoc. 2020; 9(18):e018403. PMC: 7727003. DOI: 10.1161/JAHA.120.018403. View

Oka T, Akazawa H, Sase K, Hatake K, Komuro I . Cardio-Oncology in Japan: The Rapidly Rising Sun. JACC CardioOncol. 2021; 2(5):815-818. PMC: 8352098. DOI: 10.1016/j.jaccao.2020.10.014. View

Levis B, Binkley P, Shapiro C . Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?. Lancet Oncol. 2017; 18(8):e445-e456. DOI: 10.1016/S1470-2045(17)30535-1. View

Dang C, Yu A, Jones L, Liu J, Steingart R, Argolo D . Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the Matter. J Clin Oncol. 2016; 34(10):1030-3. PMC: 5070558. DOI: 10.1200/JCO.2015.64.5515. View

Billingham L, Malottki K, Steven N . Research methods to change clinical practice for patients with rare cancers. Lancet Oncol. 2016; 17(2):e70-e80. DOI: 10.1016/S1470-2045(15)00396-4. View